Role of angiotensin II in tubulointerstitial injury

Seminars in Nephrology

Volumn 21, Issue 6, 2001, Pages 554-562

  Cao, Zemin ^a   Cooper, Mark E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; CHEMOKINE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MATRIX PROTEIN; OSTEONECTIN; OSTEOPONTIN; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BLOOD PRESSURE; CELL INFILTRATION; CELL PROLIFERATION; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY INJURY; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0035183583     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1053/snep.2001.26794     Document Type: Article

References (55)

1. Link between angiotensin II and TGF-beta in the kidney
2. Tissue-specific regulation of growth factors and clusterin by angiotensin II
3. Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system
4. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy - Implications for the pathogenesis of tubulointerstitial fibrosis
5. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation
6. Blockade of the renin angiotensin and endothelin systems on progressive renal injury
7. Expression of transforming growth factor-beta 1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: Effects of ACE inhibition
8. The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?
9. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy
10. A new model of diabetic nephropathy with progressive renal impairment in the transgenic (Mren-2)27 rat (Tgr)
11. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2) 27 rat
12. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice
13. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice
14. Additive hypotensive and antialbuminuric effects of angiotensin converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rat
15. Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy
16. Increased expression of TGF-beta-1 messenger RNA in the obstructed kidney of rats with unilateral ureteral ligation
17. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction
18. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy
19. The expression of mRNA for tumour necrosis factor-alpha increases in the obstructed kidney of rats soon after unilateral ureteral ligation
20. Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy
21. Insights into chronic cyclosporine nephrotoxicity
22. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction
23. Regulation of proximal tubular osteopontin in experimental hydronephrosis in the rat
24. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis
25. Tubulointerstitial disease in glomerulonephritis - Potential role of osteopontin (uropontin)
26. Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis
27. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis
28. Pathogenesis of cyclosporine nephropathy - Roles of angiotensin II and osteopontin
29. Osteopontin expression in fetal and mature human kidney
30. Osteopontin expression in progressive renal injury in remnant kidney: Role of angiotensin II
31. Increased osteopontin expression following renal ablation was attenuated by angiotensin type 1 receptor antagonism
32. Osteopontin is produced by rat cardiac fibroblasts and mediates a(II)-induced DNA synthesis and collagen gel contraction
33. Myocardial osteopontin expression coincides with the development of heart failure
34. The angiotensin type 2 receptor is expressed in adult rat kidney and promotes cellular proliferation and apoptosis
35. SPARC is expressed in renal interstitial fibrosis and in renal vascular injury
36. Secreted protein acidic and rich in cysteine expression after subtotal nephrectomy and blockade of the renin-angiotensin system
37. Macrophage and myofibroblast proliferation in remnant kidney: Role of angiotensin II
38. Role of TNFR 1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy
39. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells: Role of the angiotensin type 2 receptor
40. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation
41. IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro
42. Enalapril decreases nuclear factor kappa-B activation in the kidney with ureteral obstruction
43. Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring
44. Angiotensin II activates nuclear transcription factor kappa B through AT(1) and AT(2) in vascular smooth muscle cells - Molecular mechanisms
45. Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappa B (NF-kappa B) transcription factor
46. Effect of angiotensin on the filtration of protein in the rat kidney: A micropuncture study
47. Role of aldosterone in the remnant kidney model in the rat
48. Pathophysiology of progressive nephropathies
49. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria
50. Experimental models of nephron reduction: Some answers, many questions
51. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats
52. Mesangial cell apoptosis - The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis
53. Apoptosis and resolution of experimental renal infective tubulointerstitial nephritis
54. Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs
55. Apoptosis and angiotensin II; Yet another renal regulatory system